← Leaderboards
Christine T Pham
Washington University
$10,070,288
Attributed
$13,125,787
Total exposure
15
Grants
9
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $2.1M · FY2005–25$2.5M$1.9M$1.3M$625K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$19,195,123 · 14
VA$0 · 2
By mechanism
R01$9,550,392 · 4
P30$7,890,985 · 5
R21$795,685 · 2
R61$392,761 · 1
R56$342,000 · 1
K08$223,300 · 1
Top collaborators
- Farshid Guilak10 shared
- Deborah J Lenschow8 shared
- Samuel A Wickline5 shared
- Dennis E. Hourcade2 shared
- Erik Herzog1 shared
Most similar at Washington University
Same institution · by research overlap
- Sean P. J. Whelan$36,954,740
- Wayne M. Yokoyama$86,270,787
- Deborah J Lenschow$10,764,209
- Daniel P Schuster$3,913,518
- David L. Brody$4,287,870
Others in their field
Top investigators on “Inflammation”
- Glenda E Gray · Wits Health Consortium (Pty), Ltd$196,976,947
- Lawrence Corey · Fred Hutchinson Cancer Center$196,976,947
- Sharon L Hillier · Magee-Women'S Hospital Of Upmc$89,523,713
- David Heimbrook · Leidos Biomedical Research, Inc.$85,243,263
- Randall J Bateman · Washington University$64,707,456
- Peter Scott Heeger · Case Western Reserve University$56,547,884
Research focus
InflammationInflammatoryBaseResponseCellsMouse ModelDesignComplexProductionIn VitroTissuesArthritisProgramsMusculoskeletalChronicCytokineRheumatoid ArthritisIn VivoTnf GeneUniversitiesAffectWashingtonAcuteNext Generation
Grant awards (66)
Washington University Rheumatic Diseases Research Resource-based Center$699,748
P30 · FY2025 · AR · contact PI
Genetically-engineered stem cells for self-regulating arthritis therapy$538,446
R01 · FY2025 · AR
Genetically-engineered stem cells for self-regulating arthritis therapy$186,054
R01 · FY2025 · AR
Administrative Core$184,400
P30 · FY2025 · AR · contact PI
Washington University Rheumatic Diseases Research Resource-based Center$777,498
P30 · FY2024 · AR · contact PI
Genetically-engineered stem cells for self-regulating arthritis therapy$538,446
R01 · FY2024 · AR
Administrative Core$204,888
P30 · FY2024 · AR · contact PI
Genetically-engineered stem cells for self-regulating arthritis therapy$186,054
R01 · FY2024 · AR
Targeted nanotherapy for the prevention of post-traumatic osteoarthritis$0
I01 · FY2024 · VA · contact PI
Washington University Rheumatic Diseases Research Resource-based Center$777,498
P30 · FY2023 · AR · contact PI
Genetically-engineered stem cells for self-regulating arthritis therapy$555,099
R01 · FY2023 · AR
Synthetic Chronogenetic Gene Circuits for Circadian Cell Therapies$376,310
R21 · FY2023 · AR
Administrative Core$204,888
P30 · FY2023 · AR · contact PI
Genetically-engineered stem cells for self-regulating arthritis therapy$186,652
R01 · FY2023 · AR
Targeted nanotherapy for the prevention of post-traumatic osteoarthritis$0
I01 · FY2023 · VA · contact PI
Washington University Rheumatic DiseasesResearch Resource-based Center$744,893
P30 · FY2022 · AR · contact PI
Genetically-engineered stem cells for self-regulating arthritis therapy$676,370
R01 · FY2022 · AR
Administrative Core$206,644
P30 · FY2022 · AR · contact PI
Genetically-engineered stem cells for self-regulating arthritis therapy$116,490
R01 · FY2022 · AR
Targeted nanotherapy for the prevention of post-traumatic osteoarthritis$0
I01 · FY2022 · VA · contact PI
Washington University Rheumatic DiseasesResearch Resource-based Center$754,302
P30 · FY2021 · AR · contact PI
Administrative Core$206,642
P30 · FY2021 · AR · contact PI
Targeted nanotherapy for the prevention of post-traumatic osteoarthritis$0
I01 · FY2021 · VA · contact PI
Washington University Rheumatic DiseasesResearch Resource-based Center$764,955
P30 · FY2020 · AR · contact PI
Administrative Core$334,080
P30 · FY2020 · AR · contact PI
Immune-mediated pathways in pathogenesis of abdominal aortic aneurysm$0
I01 · FY2020 · VA · contact PI
Washington University Rheumatic DiseasesResearch Resource-based Center$772,944
P30 · FY2019 · AR · contact PI
Engineering smart cells for arthritis therapy$392,761
R61 · FY2019 · AR
Inhibition of NF-kB with siRNA/Peptide Nanoparticles for Arthritis Treatment$362,701
R01 · FY2019 · AR · contact PI
Administrative Core$205,986
P30 · FY2019 · AR · contact PI
Immune-mediated pathways in pathogenesis of abdominal aortic aneurysm$0
I01 · FY2019 · VA · contact PI
Washington University Rheumatic DiseasesResearch Resource-based Center$777,498
P30 · FY2018 · AR · contact PI
Inhibition of NF-kB with siRNA/Peptide Nanoparticles for Arthritis Treatment$362,701
R01 · FY2018 · AR · contact PI
Administrative Core$204,018
P30 · FY2018 · AR · contact PI
Immune-mediated pathways in pathogenesis of abdominal aortic aneurysm$0
I01 · FY2018 · VA · contact PI
Inhibition of NF-kB with siRNA/Peptide Nanoparticles for Arthritis Treatment$362,701
R01 · FY2017 · AR · contact PI
REGULATION OF COMPLEMENT ACTIVATION BY SALP20 PROTEIN$190,625
R21 · FY2017 · AI
Immune-mediated pathways in pathogenesis of abdominal aortic aneurysm$0
I01 · FY2017 · VA · contact PI
Inhibition of NF-kB with siRNA/Peptide Nanoparticles for Arthritis Treatment$362,701
R01 · FY2016 · AR · contact PI
REGULATION OF COMPLEMENT ACTIVATION BY SALP20 PROTEIN$228,750
R21 · FY2016 · AI
Peptide-siRNA Nanotherapeutics for Osteoarthritis$70,103
P30 · FY2016 · AR · contact PI
Immune-mediated pathways in pathogenesis of abdominal aortic aneurysm$0
I01 · FY2016 · VA · contact PI
Inhibition of NF-kB with siRNA/Peptide Nanoparticles for Arthritis Treatment$362,701
R01 · FY2015 · AR · contact PI
Immune-mediated pathways in pathogenesis of abdominal aortic aneurysm$0
I01 · FY2015 · VA · contact PI
ROLE OF DPPI & SERINE PROTEASES IN INFLAMMATORY DISEASES$372,438
R01 · FY2012 · AI · contact PI
Targeted Nanotherapy in the Treatment of Inflammatory Arthritis$317,814
R01 · FY2012 · AR · contact PI
ROLE OF DPPI & SERINE PROTEASES IN INFLAMMATORY DISEASES$372,438
R01 · FY2011 · AI · contact PI
Targeted Nanotherapy in the Treatment of Inflammatory Arthritis$317,814
R01 · FY2011 · AR · contact PI
ROLE OF DPPI & SERINE PROTEASES IN INFLAMMATORY DISEASES$376,200
R01 · FY2010 · AI · contact PI
Targeted Nanotherapy in the Treatment of Inflammatory Arthritis$331,056
R01 · FY2010 · AR · contact PI
ROLE OF DPPI & SERINE PROTEASES IN INFLAMMATORY DISEASES$50,008
R01 · FY2010 · AI · contact PI
ROLE OF DPPI & SERINE PROTEASES IN INFLAMMATORY DISEASES$10,263
R01 · FY2010 · AI · contact PI
ROLE OF DPPI & SERINE PROTEASES IN INFLAMMATORY DISEASES$380,000
R01 · FY2009 · AI · contact PI
Targeted Nanotherapy in the Treatment of Inflammatory Arthritis$334,400
R01 · FY2009 · AR · contact PI
TARGETED NANOTHERAPY IN THE TREATMENT OF INFLAMMATORY ARTHRITIS$334,400
R01 · FY2008 · AR · contact PI
ROLE OF DPPI & SERINE PROTEASES IN INFLAMMATORY DISEASES$237,500
R01 · FY2008 · AI · contact PI
Role of DPPI & Serine Proteases in Inflammatory Diseases$342,000
R56 · FY2007 · AI · contact PI
Role of DPPI & Serine Proteases in Inflammatory Diseases$261,459
R01 · FY2006 · AI · contact PI
Role of DPPI &Serine Proteases in Inflammatory Diseases$267,750
R01 · FY2005 · AI
Role of DPPI &Serine Proteases in Inflammatory Diseases$267,750
R01 · FY2004 · AI
Role of DPPI &Serine Proteases in Inflammatory Diseases$267,750
R01 · FY2003 · AI
Role of DPPI &Serine Proteases in Inflammatory Diseases$254,236
R01 · FY2002 · AI
ROLE OF DPP1 AND GRANZYMES IN INFLAMMATORY ARTHRITIS$0
P30 · FY2002 · AR
DPPI AND CELL MEDIATED IMMUNITY$111,650
K08 · FY2001 · HL
ROLE OF DPP1 AND GRANZYMES IN INFLAMMATORY ARTHRITIS$0
P30 · FY2001 · AR
DPPI AND CELL MEDIATED IMMUNITY$111,650
K08 · FY2000 · HL